Intraperitoneal therapy for ovarian cancer: a treatment ready for prime time.
Armstrong
Deborah K
DK
Johns Hopkins Kimmel Cancer Center, Baltimore, MD, USA.
Brady
Mark F
MF
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal / Q000592:standards*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D000970:Antineoplastic Agents